In Silico Drug Discovery: Solving the “Target‐rich and Lead‐poor” Imbalance Using the Genome‐to‐drug‐lead Paradigm
暂无分享,去创建一个
[1] M. Karplus,et al. Locally accessible conformations of proteins: Multiple molecular dynamics simulations of crambin , 1998, Protein science : a publication of the Protein Society.
[2] Lorna J. Smith,et al. Assessing equilibration and convergence in biomolecular simulations , 2002, Proteins.
[3] Jean-Charles Sanchez,et al. Proteomics: new perspectives, new biomedical opportunities , 2000, The Lancet.
[4] Michael R. Shirts,et al. Simulation of folding of a small alpha-helical protein in atomistic detail using worldwide-distributed computing. , 2002, Journal of molecular biology.
[5] Yuan-Ping Pang,et al. From genome to drug lead: Identification of a small-molecule inhibitor of the SARS virus , 2005, Bioorganic & Medicinal Chemistry Letters.
[6] A. Sali,et al. Structural genomics: beyond the Human Genome Project , 1999, Nature Genetics.
[7] Channa K. Hattotuwagama,et al. Receptor-ligand binding sites and virtual screening. , 2006, Current medicinal chemistry.
[8] Yuan-Ping Pang,et al. EUDOC: a computer program for identification of drug interaction sites in macromolecules and drug leads from chemical databases , 2001, J. Comput. Chem..
[9] D. Mccormick. Sequence the Human Genome , 1986, Bio/Technology.
[10] Y. Pang. Three‐dimensional model of a substrate‐bound SARS chymotrypsin‐like cysteine proteinase predicted by multiple molecular dynamics simulations: Catalytic efficiency regulated by substrate binding , 2004, Proteins.
[11] Y. Liu,et al. Only One Protomer Is Active in the Dimer of SARS 3C-like Proteinase* , 2006, Journal of Biological Chemistry.
[12] Mitchell A. Miller. Chemical database techniques in drug discovery , 2002, Nature Reviews Drug Discovery.
[13] Pedro Alexandrino Fernandes,et al. Protein–ligand docking: Current status and future challenges , 2006, Proteins.
[14] S H Kaufmann,et al. Successful virtual screening of a chemical database for farnesyltransferase inhibitor leads. , 2000, Journal of medicinal chemistry.
[15] V. Pande,et al. Absolute comparison of simulated and experimental protein-folding dynamics , 2002, Nature.
[16] Wesley I. Sundquist,et al. Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein , 2002, Nature Structural Biology.
[17] Y. Pang,et al. Serotype-selective, small-molecule inhibitors of the zinc endopeptidase of botulinum neurotoxin serotype A. , 2006, Bioorganic & medicinal chemistry.
[18] P. Bradley,et al. Toward High-Resolution de Novo Structure Prediction for Small Proteins , 2005, Science.
[19] 박홍석. [특강I]Beyond Human Genome Project , 2002 .
[20] R. Schmid,et al. Modeling domino effects in enzymes: molecular basis of the substrate specificity of the bacterial metallo-beta-lactamases IMP-1 and IMP-6. , 2003, Biochemistry.